Ascendis Pharma A/S (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Ascendis Pharma A/S - ADR: Is Infosys Ltd. worth buying?
Item: Ascendis Pharma A/S - ADR
Rating: 1.66100
Author: Trendlyne DVM scores

about

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, a...

215.05 6.29 (3.01%)

82.20% Gain from 52W Low

1.4M

XNAS Volume

High volume today

XNAS 13 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

5.5 / 100

Technically Moderately Bullish

60.9 / 100

264

1Yr Price target upside is 23%

15 analysts

Ascendis Pharma A/S (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..